News + Filings Transactions
|
Suri Anish
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
02/16/2023 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 125.5k | $3.21 | $402.9k | | 02/16/2023 |
03/31/2022 | Cue Biopharma, Inc. | CUE | Exercise | Restricted Stock Units | 16.7k | $0.00 | $0 | | 03/31/2022 |
03/31/2022 | Cue Biopharma, Inc. | CUE | Payment of Exercise | Common Stock | 7.1k | $4.88 | $34.5k | | 03/31/2022 |
03/25/2022 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 21.3k | $5.01 | $106.9k | | 02/09/2022 |
02/09/2022 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 82k | $6.91 | $566.6k | | 02/09/2022 |
11/15/2021 | Cue Biopharma, Inc. | CUE | Sale | Common Stock | 8k | $18.05 | $144.4k | | 11/15/2021 |
11/15/2021 | Cue Biopharma, Inc. | CUE | Exercise | Stock Option (right to buy) | 8k | $8.26 | $66.1k | | 11/15/2021 |
11/11/2021 | Cue Biopharma, Inc. | CUE | Exercise | Stock Option (right to buy) | 20k | $6.42 | $128.4k | | 11/11/2021 |
11/11/2021 | Cue Biopharma, Inc. | CUE | Sale | Common Stock | 20k | $15.07 | $301.4k | | 11/11/2021 |
10/06/2021 | Cue Biopharma, Inc. | CUE | Payment of Exercise | Common Stock | 14.1k | $12.97 | $183.3k | | 10/03/2021 |
10/03/2021 | Cue Biopharma, Inc. | CUE | Exercise | Restricted Stock Units | 33.3k | $0.00 | $0 | | 10/03/2021 |
09/23/2021 | Cue Biopharma, Inc. | CUE | Sale | Common Stock | 20k | $15.23 | $304.6k | | 09/23/2021 |
09/23/2021 | Cue Biopharma, Inc. | CUE | Exercise | Stock Option (right to buy) | 20k | $6.42 | $128.4k | | 09/23/2021 |
02/10/2021 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 75k | $15.55 | $1.2M | | 02/10/2021 |
10/05/2020 | Cue Biopharma, Inc. | CUE | Payment of Exercise | Common Stock | 9.8k | $16.30 | $159.7k | | 10/03/2020 |
10/03/2020 | Cue Biopharma, Inc. | CUE | Exercise | Restricted Stock Units | 33.3k | $0.00 | $0 | | 10/03/2020 |
08/05/2020 | Cue Biopharma, Inc. | CUE | Exercise | Stock Option (right to buy) | 800 | $6.42 | $5.1k | | 08/05/2020 |
08/05/2020 | Cue Biopharma, Inc. | CUE | Sale | Common Stock | 800 | $20.01 | $16k | | 08/05/2020 |
08/04/2020 | Cue Biopharma, Inc. | CUE | Sale | Common Stock | 400 | $20.14 | $8.1k | | 08/03/2020 |
08/04/2020 | Cue Biopharma, Inc. | CUE | Exercise | Stock Option (right to buy) | 400 | $6.42 | $2.6k | | 08/03/2020 |
08/03/2020 | Cue Biopharma, Inc. | CUE | Sale | Common Stock | 5.8k | $20.01 | $116.1k | | 08/03/2020 |
08/03/2020 | Cue Biopharma, Inc. | CUE | Exercise | Stock Option (right to buy) | 2k | $8.26 | $16.5k | | 08/03/2020 |
08/03/2020 | Cue Biopharma, Inc. | CUE | Exercise | Stock Option (right to buy) | 3.8k | $6.42 | $24.4k | | 08/03/2020 |
03/31/2020 | Cue Biopharma, Inc. | CUE | Grant | Restricted Stock Units | 50k | $0.00 | $0 | | 03/31/2020 |
03/31/2020 | Cue Biopharma, Inc. | CUE | Payment of Exercise | Common Stock | 5.4k | $0.00 | $0 | | 03/31/2020 |
03/31/2020 | Cue Biopharma, Inc. | CUE | Exercise | Restricted Stock Units | 16.7k | $0.00 | $0 | | 03/31/2020 |
02/05/2020 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 65k | $16.26 | $1.1M | | 02/05/2020 |
11/01/2019 | Cue Biopharma, Inc. | CUE | Payment of Exercise | Common Stock | 12.1k | $8.63 | $104.3k | | 11/01/2019 |
11/01/2019 | Cue Biopharma, Inc. | CUE | Exercise | Restricted Stock Units | 33.3k | $0.00 | $0 | | 11/01/2019 |
10/03/2019 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 400k | $7.53 | $3M | | 10/03/2019 |
10/03/2019 | Cue Biopharma, Inc. | CUE | Grant | Restricted Stock Units | 100k | $0.00 | $0 | | 10/03/2019 |
03/06/2019 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 150k | $6.42 | $963k | | 03/06/2019 |
03/06/2019 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 100k | $11.54 | $1.2M | | 03/06/2019 |
12/21/2018 | Cue Biopharma, Inc. | CUE | Purchase | Common Stock | 2k | $4.37 | $8.7k | | 12/21/2018 |
08/14/2018 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 20k | $8.26 | $165.2k | | 08/14/2018 |
|
|